依據99.11.11全民健康保險醫療給付協議會議確認之化療個案核實申報之化療藥品項目，包括：
1.ATC碼前3碼為L01(ANTINEOPLASTIC AGENTS)、L02(ENDOCRINE THERAPY)之健保支付品項。
2.上述品項以外項目:
| 序號 | CODE | 藥品名稱 | ATC7碼 | 價格生效日 |
|---|---|---|---|---|
| 1 | KC00670282 | FILGRASTIM INJECTION M300 | L03AA02 | 104.01.01 |
| 2 | KC00711280 | FILGRASTIM INJECTION 150 μG/0.6ML | L03AA02 | 104.01.01 |
| 3 | KC00712266 | FILGRASTIM INJECTION 75 μG/0.3ML | L03AA02 | 104.01.01 |
| 4 | KC00756265 | GRANOCYTE 250 | L03AA10 | 104.01.01 |
| 5 | KC00757255 | GRANOCYTE 100 | L03AA10 | 104.01.01 |
| 6 | KC00700216 | ROFERON-A (SOLUTION FOR INJECTION) | L03AB04 | 104.04.01 |
| 7 | K000700220 | ROFERON-A (SOLUTION FOR INJECTION) | L03AB04 | 100.12.01 |
| 8 | K000700223 | ROFERON-A (SOLUTION FOR INJECTION) | L03AB04 | 100.12.01 |
| 9 | KC00589237 | INTRON A MULTIDOSE PEN 15MIU/ML 1.2ML | L03AB05 | 104.02.01 |
| 10 | K000650237 | PROLEUKIN FOR INJECTION | L03AC01 | 104.04.01 |
| 11 | BC19924221 | PICIBANIL 5KE | J01CE01 | 104.04.01 |
| 12 | KC003692BC | BCG IMMUNOTHERAPEUTIC IMMUCYST | L03AX03 | 104.02.01 |
| 13 | BC19316109 | KRESTIN | L01XX | 104.01.01 |
| 14 | AB48969100 | THADO CAPSULES 50 MG | L04AX02 | 104.04.01 |